Farrawell Natalie E, Yerbury Justin J
Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.
School of Chemistry and Molecular Bioscience and Molecular Horizons, University of Wollongong, Wollongong, NSW, Australia.
Front Mol Neurosci. 2021 Nov 3;14:771911. doi: 10.3389/fnmol.2021.771911. eCollection 2021.
SOD1 mutations account for ∼20% of familial amyotrophic lateral sclerosis (ALS) cases in which the hallmark pathological feature is insoluble SOD1 aggregates within motor neurons. Here, we investigated the degradation and synthesis of mutant SOD1 to determine whether the aggregation of mutant SOD1 affects these processes. We confirm that, in general, the degradation of mutant SOD1 occurs at a significantly faster rate than wild-type SOD1. We also report that the turnover and synthesis of mutant SOD1 is impaired in the presence of insoluble SOD1 aggregates. However, the timing of aggregation of SOD1 did not coincide with UPS dysfunction. Together, these results reveal the impact of SOD1 aggregation on protein degradation pathways, highlighting the importance of the UPS in preventing neurodegenerative disorders such as ALS.
超氧化物歧化酶1(SOD1)突变约占家族性肌萎缩侧索硬化症(ALS)病例的20%,其中标志性病理特征是运动神经元内不溶性SOD1聚集体。在此,我们研究了突变型SOD1的降解和合成,以确定突变型SOD1的聚集是否会影响这些过程。我们证实,一般来说,突变型SOD1的降解速度明显快于野生型SOD1。我们还报告称,在存在不溶性SOD1聚集体的情况下,突变型SOD1的周转和合成受损。然而,SOD1聚集的时间与泛素-蛋白酶体系统(UPS)功能障碍并不一致。这些结果共同揭示了SOD1聚集对蛋白质降解途径的影响,突出了UPS在预防诸如ALS等神经退行性疾病中的重要性。